
6, Rue Ibn Ennafis - Z.I. Lac 3 Tunisie
Tél. : 71 182 500 - Fax : 71 182 250
www.biomaghreb.com
IVD
FT En 29 Date of updating : 10/ 2020 Version B
IN VITRO DIAGNOSTIC USE
Manufacturer Use by In Vitro Diagnostic Temperature
Limitation
Catalogue number See insert Store away from light Sufcient
for < n > essais
Batch number
CLINICAL SIGNIFICANCE
Urea is a molecule resulting from the process of protein catabolism, eliminated by the kidneys in the
form of nitrogenous waste products.
Determination of urea levels therefore makes it possible to assess renal function, particularly in dia-
betics and patients who have suffered a myocardial infarction. In the case of renal dysfunction, there
is an increase in uremia. In addition, certain liver diseases can also alter the level of urea in the blood.
The urea dosage alone is not very informative, since the urea produced each day varies according
to diet, age and hydration status. For this reason, creatinine and uric acid determinations are usually
done at the same time. In addition, the determination of urea clearance is used to evaluate the filtra-
tion rate of the kidneys and the efficiency of dialysis.
PRINCIPLE
Enzymatic method based on the reaction principle described by Talke and Schubert :
The decrease in absorbance following the conversion of NADH to NAD+ at 340 nm is proportional to
the concentration of urea in the sample.
Urease
Urea + H
2
2NH
3
+ CO
2
2NH
4
+
+ Oxo-2-glutarate + NADH
GLDH
Glutamate + NAD
+
+ 2H
2
O
GLDH : Glutamate dehydrogenase
REAGENT COMPOSITION
Reagent 1
Buffer solution
Buffer Tris pH 8 80 mmol/l
Reagent 2
Enzymes
Urease
GLDH
NADH
Oxo-2-glutarate
>10 000U/l
16 000 U/l
0.30 mmol/l
15 mmol/l
Reagent 3
Standard
Standard Urea
50 mg/dl
8.325 mmol/l
SAFETY CAUTIONS
Biomaghreb reagents are intended for use by qualified personnel for in vitro use (do not pipette by
mouth).
• Refer to the current SDS available on request or at www.biomaghreb.com;
• Verify the integrity of the reagents before use; and
• Disposal of waste: comply with the legislation in force.
For safety reasons, treat any specimen or reagent of biological origin as potentially infectious.
Respect the legislation in force.
REAGENT PREPARATION
Working solution :
Dissolve a vial of R2 in a vial of R1.
SAMPLE PREPARATION
Serum, plasma collected on heparin.
Urine diluted 1:100 with distilled water.
PRESERVATION AND STABILITE
• Before opening : Until the expiry date indicated on the label of the box at 2-8°C;
• After opening : (working solution) :
5 days at 20 -25°C ;
3 weeks at 2-8°C.
ADDITIONAL EQUIPMENT
• Basic equipment of the medical analysis laboratory ;
• Spectrophotometer or Clinical Biochemistry Analyzer.
LIMITS
Do not use anticoagulants containing fluoride or ammonium ions.
QUALITY CONTROL
External quality control program.
It is recommended to control in the following cases:
• At least one test per series.
• Change of reagent bottle.
• After maintenance work on the analyzer.
If a control value is outside the confidence limits, repeat the procedure using the same control.
Use normal and pathological control sera.
CALIBRATION
The standard of the kit (Reagent 3) or any calibrator connected to a method or reference material.
The frequency of calibration depends on analyzer performance and reagent storage conditions.
Recalibration is recommended in the following cases:
1. Changing the reagent lot;
2. After maintenance work on the analyzer; and
3. Control values are outside the confidence limits.
LINEARITY
The method is linear up to 2 g/l (200 mg/dl - 33.3mmol/l).
PROCEDURE
Wavelength: 340 nm ;
Temperature : 25-30-37°C ;
Tank : 1 cm thick;
Adjust the spectrophotometer zero to air or distilled water.
Standard Sample
Working solution
1 ml 1 ml
Preincubate at selected temperature 25, 30, 37°C
Reagent 3
10 µl --
Sample
-- 10 µl
Mix, measure the decrease in OD between :
t = 20 secondes and t = 80 secondes.
CALCULATION
Urea =
Δ OD Sample
Δ OD Standard
x n
n = Standard value
n = 50 mg/dl;
n = 0, 5 g/l;
n = 8,325 mmol/l.
REFERENCE VALUES
Serum or
plasma
15 - 40 mg/dl
0,15 – 0,40 g/l
2,49 – 6,66 mmol/l
Urine 20 - 35 g/24 h
REFERENCES
Talke H, Schubert GE 1965. Klin Wochenschr 43:174-5 ;
Chaney, A. Clin. 8, 130 (1962) ;
Fawcett J.K., J. Clin. Path.13, 15 (1960).
UREA
Kinetic Test U.V
Reagent for the quantitative determination of urea
in human plasma and urine.